SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile

OBJECTIVES: As coronavirus disease 2019 (COVID-19) rages on worldwide, there is an urgent need to characterize immune correlates of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify immune determinants of COVID-19 severity. METHODS: This study exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacharathit, Vimvara, Srichatrapimuk, Sirawat, Manopwisedjaroen, Suwimon, Kirdlarp, Suppachok, Srisaowakarn, Chanya, Setthaudom, Chavachol, Inrueangsri, Nanthicha, Pisitkun, Prapaporn, Kunakorn, Mongkol, Hongeng, Suradej, Sungkanuparph, Somnuek, Thitithanyanont, Arunee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442529/
https://www.ncbi.nlm.nih.gov/pubmed/34536610
http://dx.doi.org/10.1016/j.ijid.2021.09.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442529/
https://www.ncbi.nlm.nih.gov/pubmed/34536610
http://dx.doi.org/10.1016/j.ijid.2021.09.021

Ejemplares similares